NCT05935748 2025-11-12Ph2 Study NKT2152 With Palbociclib & Sasanlimab in Subjects With Advanced Clear Cell Renal Cell Carcinoma (ccRcc)NiKang Therapeutics, Inc.Phase 2 Terminated18 enrolled
NCT03769467 2024-11-14Tabelecleucel in Combination With Pembrolizumab in Subjects With Epstein-Barr Virus-associated Nasopharyngeal Carcinoma (EBV+ NPC)Atara BiotherapeuticsPhase 1/2 Terminated12 enrolled 8 charts
NCT01234480 2023-05-16Intended Use Study of the BD SurePath Plusâ„¢ PapBecton, Dickinson and CompanyTerminated5,859 enrolled 4 charts
NCT00481936 2023-03-23Study of the Safety of VB6-845 in Patients With Advanced Solid Tumours of Epithelial OriginSesen Bio, Inc.Phase 1 Terminated15 enrolled
NCT01009593 2012-09-10Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)AbbottPhase 3 Terminated1,035 enrolled